Caricamento...
Subcutaneous to Intravenous Prostacyclin Analogue Transition in Pulmonary Hypertension
INTRODUCTION: Prostacyclin analogues are FDA-approved therapies for the treatment of Pulmonary Arterial Hypertension (PAH) and can be administered by inhalational, intravenous (IV) or subcutaneous (SQ) routes. Since there is limited data to guide the transition between SQ to IV prostacyclin analogue...
Salvato in:
| Pubblicato in: | J Cardiovasc Pharmacol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4662283/ https://ncbi.nlm.nih.gov/pubmed/24084219 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FJC.0000000000000018 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|